 |
 |
Market research to gain the competitive edge |
|
 |
|
|
|
|
|
|
|
|
|
|
Biopharmaceutical
Contract Manufacturing 2007:
Quality, Capacities and Emerging Technologies |
|
| The Comprehensive Industry Report
for 2007 |
|
|
-
Learn
how improved process development, higher yields and cell
line development, use of disposables, capacity expansions,
and increased efficiencies are impacting biopharmaceutical
contract manufacturing.
- Find out what opportunities
exist for the production of various biologics, including
recombinant protein therapeutics, monoclonal antibodies,
antibody fragments, antibody drug conjugates, fusion proteins
and more
- Understand market
size and growth dynamics and how contractors are succeeding
in this marketplace.
|
|
| The Ph.D. and MBA analysts provide an in-depth analysis of the contract biomanufacturing market. |
|
| Report Overview | |
|
This 800-page report,
the comprehensive 2007 industry report, provides the latest
information on biomanufacturing strategies, new products and
manufacturing efficiencies, expression systems and cell lines,
capacity additions, new equipment, challenges for the industry,
and expanded outsourcing services so readers can make the
most successful strategic decisions. The data and the analysis
in this report are based on 68 in-depth interviews conducted
with biomanufacturing directors at pharmaceutical and biotechnology
companies and contractor companies worldwide. It is the most
comprehensive industry report on biopharmaceutical contract
manufacturing.
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fax or Mail Order Form to HighTech Business Decisions
|
|